GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » PB Ratio

Rhythm Pharmaceuticals (FRA:1RV) PB Ratio : 144.14 (As of Apr. 02, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-02), Rhythm Pharmaceuticals's share price is €48.00. Rhythm Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was €0.33. Hence, Rhythm Pharmaceuticals's PB Ratio of today is 144.14.

The historical rank and industry rank for Rhythm Pharmaceuticals's PB Ratio or its related term are showing as below:

FRA:1RV' s PB Ratio Range Over the Past 10 Years
Min: 0.69   Med: 5.58   Max: 367.92
Current: 143.68

During the past 10 years, Rhythm Pharmaceuticals's highest PB Ratio was 367.92. The lowest was 0.69. And the median was 5.58.

FRA:1RV's PB Ratio is ranked worse than
99.53% of 1277 companies
in the Biotechnology industry
Industry Median: 2.26 vs FRA:1RV: 143.68

During the past 12 months, Rhythm Pharmaceuticals's average Book Value Per Share Growth Rate was -87.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -60.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -35.90% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Rhythm Pharmaceuticals was -7.60% per year. The lowest was -60.50% per year. And the median was -9.90% per year.

Back to Basics: PB Ratio


Rhythm Pharmaceuticals PB Ratio Historical Data

The historical data trend for Rhythm Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals PB Ratio Chart

Rhythm Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.82 1.86 6.31 15.88 159.16

Rhythm Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.88 41.77 62.54 281.71 159.16

Competitive Comparison of Rhythm Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, Rhythm Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhythm Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rhythm Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rhythm Pharmaceuticals's PB Ratio falls into.


;
;

Rhythm Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rhythm Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=48.00/0.333
=144.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Rhythm Pharmaceuticals  (FRA:1RV) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rhythm Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhythm Pharmaceuticals Business Description

Traded in Other Exchanges
Address
222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Rhythm Pharmaceuticals Headlines

No Headlines